Clinical Trial: 15-Hydroxyprostaglandin Dehydrogenase in Osteoarthritis and Ankylosing Spondylitis

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07751263) titled '15-Hydroxyprostaglandin Dehydrogenase in Osteoarthritis and Ankylosing Spondylitis' on Aug. 03.

Brief Summary: To evaluate serum and synovial fluid 15-PGDH levels in patients with osteoarthritis and ankylosing spondylitis and determine their associations with clinical and musculoskeletal ultrasound features.

To compare 15-PGDH concentrations among patients with knee osteoarthritis, and ankylosing spondylitis with knee effusion

To evaluate whether serum 15-PGDH reflects intra-articular 15-PGDH concentrations.

Analysis the level of 15-PGDH in relation to disease activity and severity of both diseases.

Study Start Date: Aug. 02

Stu...